Mitral-valve repair versus replacement for severe ischemic mitral regurgitation

New England Journal of Medicine

Volumn 370, Issue 1, 2014, Pages 23-32

  Acker, Michael A ^a   Parides, Michael K ^b   Perrault, Louis P ^e   Moskowitz, Alan J ^b   Gelijns, Annetine C ^b   Voisine, Pierre ^f   Smith, Peter K ^g   Hung, Judy W ⁱ   Blackstone, Eugene H ^k   Puskas, John D ^l   Argenziano, Michael ^c   Gammie, James S ^m   Mack, Michael ⁿ   Ascheim, Deborah D ^b   Bagiella, Emilia ^b   Moquete, Ellen G ^b   Ferguson, T Bruce ^h   Horvath, Keith A ^o   Geller, Nancy L ^o   Miller, Marissa A ^o   Woo, Y Joseph ^a   D'Alessandro, David A ^d   Ailawadi, Gorav ^p   Dagenais, Francois ^f   Gardner, Timothy J ^q   O'Gara, Patrick T ^j   Michler, Robert E ^d   Kron, Irving L ^p   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Columbia University ^*  (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e MONTREAL HEART INSTITUTE   (Canada)

^f LAVAL UNIVERSITY   (Canada)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h EAST CAROLINA UNIVERSITY   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k LERNER RESEARCH INSTITUTE   (United States)

^l EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

ⁿ BAYLOR RESEARCH INSTITUTE   (United States)

^o NATIONAL INSTITUTES OF HEALTH   (United States)

^p UNIVERSITY OF VIRGINIA   (United States)

^q CHRISTIANA CARE HEALTH SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR EFFECT; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; MULTICENTER STUDY; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY FAILURE; RISK BENEFIT ANALYSIS; SEPSIS; SURGICAL MORTALITY; TREATMENT OUTCOME; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; CORONARY ARTERY DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; HEART VALVE REPLACEMENT; HEART VENTRICLE REMODELING; MIDDLE AGED; MITRAL ANNULOPLASTY; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROPORTIONAL HAZARDS MODEL;

AGED; CORONARY ARTERY DISEASE; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; RECURRENCE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84891123882     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1312808     Document Type: Article

References (41)

1. Lamas GA, Mitchell GF, Flaker G.C., et al Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation 1997;96:827-33.
2. Grigioni F, Enriquez-Sarano M, Zehr K.J., Bailey KR, Tajik AJ Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001; 103:1759-64.
3. Ellis SG, Whitlow PL, Raymond R.E., Schneider JP Impact of mitral regurgitation on long-term survival after percutaneous coronary intervention. Am J Cardiol 2002;89:315-8.
4. Di Salvo T.G., Acker MA, Dec G.W., Byrne JG Mitral valve surgery in advanced heart failure. J Am Coll Cardiol 2010; 55: 271-82.
5. Bonow RO, Carabello BA, Kanu C, et al ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114(5):e84-e231. [Errata, Circulation 2007;115(15):e409, 2010;121(23):e443.]
6. The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-96.
7. Gillinov AM, Wierup PN, Blackstone E.H., et al Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2001; 122: 1125-41.
8. Grossi EA, Goldberg JD, LaPietra A, et al Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg 2001;122:1107-24.
9. Reece TB, Tribble CG, Ellman P.I., et al Mitral repair is superior to replacement when associated with coronary artery disease. Ann Surg 2004; 239: 671-5.
10. Al-Radi O.O., Austin PC, Tu J V, David TE, Yau TM Mitral repair versus replacement for ischemic mitral regurgitation. Ann Thorac Surg 2005; 79: 1260-7.
11. Zoghbi WA, Enriquez-Sarano M, Foster E., et al Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
12. Perrault LP, Moskowitz AJ, Kron I.L., et al Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg 2012;143:1396-403.
13. Bax JJ, Braun J, Somer S.T., et al Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 2004; 110: Suppl 1:II-103-II-108.
14. Yiu SF, Enriquez-Sarano M, Tribouilloy C., Seward JB, Tajik AJ Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 2000; 102: 1400-6.
15. Kang DH, Kim MJ, Kang S.J., et al Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation. Circulation 2006; 114: Suppl:I-499-I-503.
16. O'Brien P.C., Fleming TR A multiple testing procedure for clinical trials. Biomet rics 1979;35:549-56.
17. Lan KKG, DeMets DL Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
18. Gammie JS, Sheng S, Griffith B.P., et al Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2009; 87: 1431-7.
19. Solomon SD, Skali H, Anavekar N.S., et al Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation 2005;111:3411-9.
20. Di Donato M., Castelvecchio S, Menicanti L. End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy. Eur J Heart Fail 2010;12:375-81.
21. Mann DL, Bristow MR Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005;111:2837-49. [Erratum, Circulation 2005;112(4):e75.]
22. Society of Thoracic Surgeons. Adult cardiac surgery database: executive summary: Harvest 1, 2013. (http://www.sts.org/sites/default/files/documents/ 1stHarvestExecutiveSummary.pdf).
23. Thourani VH, Weintraub WS, Guyton R.A., et al Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation 2003;108:298-304.
24. Micovic S, Milacic P, Otasevic P., et al Comparison of valve annuloplasty and replacement for ischemic mitral valve incompetence. Heart Surg Forum 2008; 11: E340-E345.
25. Milano CA, Daneshmand MA, Rankin J.S., et al Survival prognosis and surgical management of ischemic mitral regurgitation. Ann Thorac Surg 2008; 86: 735-44.
26. Silberman S, Oren A, Klutstein M.W., et al Does mitral valve intervention have an impact on late survival in ischemic cardiomyopathy? Isr Med Assoc J 2006; 8: 17-20.
27. Vassileva CM, Boley T, Markwell S, Hazelrigg S. Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg 2011;39:295-303.
28. Magne J, Girerd N, Sénéchal M, et al. Mitral repair versus replacement for ische mic mitral regurgitation: comparison of short-term and long-term survival. Circulation 2009;120:Suppl:S104-S111.
29. McGee EC, Gillinov AM, Blackstone E.H., et al Recurrent mitral regurgitation after annuloplasty for functional is chemic mitral regurgitation. J Thorac Cardiovasc Surg 2004;128:916-24.
30. Magne J, Sénéchal M, Dumesnil JG, Pibarot P. Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology 2009;112:244-59.
31. Hung J, Papakostas L, Tahta S.A., et al Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation 2004;110:Suppl 1:II-185-II-190.
32. Levine RA, Schwammenthal E. Ische mic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 2005; 112:745-58.
33. Bouchard D, Jensen H, Carrier M., et al Effect of systematic downsizing rigid ring annuloplasty in patients with moderate ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2013.
34. Konstam MA, Udelson JE, Anand I.S., Cohn JN Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Fail 2003; 9: 350-3.
35. Carson P, Tognoni G, Cohn JN Effect of valsartan on hospitalization: results from Val-HeFT. J Card Fail 2003; 9: 164-71.
36. Kramer DG, Trikalinos TA, Kent D.M., Antonopoulos GV, Konstam MA, Udelson JE Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol 2010; 56: 392-406.
37. White HD, Norris RM, Brown M.A., Brandt PW, Whitlock RM, Wild CJ Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
38. St John Sutton M, Pfeffer MA, Moye L, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 1997;96:3294-9.
39. Moss AJ, Hall WJ, Cannom D.S., et al Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
40. Ghio S, Freemantle N, Scelsi L., et al Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail 2009; 11: 480-8.
41. Years 2008-2012: the Adult Cardiac Surgery Database. Chicago: Society of Thoracic Surgeons (http://www.sts.org/national-database).